MarketBeat
08 Aug 2026, 05:04 UTC · 1h ago
Emergent Biosolutions Q2 Earnings Call Highlights
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
MarketBeat
08 Aug 2026, 05:04 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
6 claims · each scored for market impact
Emergent Biosolutions lowered its full-year 2026 revenue guidance from $720–$760 million to $645–$675 million. — A significant downward revision in top-line growth typically triggers a negative price reaction as it signals deteriorating fundamentals.
-0.80The company recorded a non-cash impairment charge of approximately $191 million related to the NARCAN asset group due to competitive and pricing pressures. — Large impairments indicate a permanent write-down in the value of a core asset, signaling diminished future cash flows from a primary product.
-0.60Increased competition and aggressive pricing in the naloxone market are expected to weigh on NARCAN sales. — Market share erosion and price compression in a lead commercial product threaten long-term margins and revenue stability.
-0.50Continue reading
6 related stories
Top 3 movers · tap to explore
Second-quarter revenue ($234 million) and adjusted EBITDA ($97 million) both exceeded prior guidance and analyst consensus. — Strong short-term execution and beats on key metrics provide a positive offset to the lowered long-term outlook.
+0.40Which stocks this story touches
Strong Q2 results and medical countermeasure growth are offset by a lowered full-year guidance, a $191 million impairment charge, and pricing pressure for NARCAN.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
Seeking Alpha
1h ago
